Why Choose Us?
0% AI Guarantee
Human-written only.
24/7 Support
Anytime, anywhere.
Plagiarism Free
100% Original.
Expert Tutors
Masters & PhDs.
100% Confidential
Your privacy matters.
On-Time Delivery
Never miss a deadline.
1) PDL Biopharma, Inc
1) PDL Biopharma, Inc., a biotechnology company, reported net income (amounts in thousands) of $91,874 for Year 10. The weighted average of common shares outstanding during Year 10 was 126,578 shares. PDL Biopharma, Inc., subtracted interest expense net of tax saving on convertible debt of $5,087. If the convertible debt had been converted into common stock, it would have increased the weighted-average common shares outstanding by 52,111 shares. PDL Biopharma, Inc., has outstanding stock options and other dilutive securities that if exercised, would increase the weighted average of common shares outstanding by 112 shares.
- Basic earnings per share for Year 10 equals _________
- Diluted earnings per share for Year 10 equals _________
Expert Solution
Computation of Basic Earnings per Share:
Basic Earnings per Share = Net Income/Average Outstanding Shares
= $91,784,000/126,578
Basic Earnings per Share = $725.12
Computation of Diluted Earnings per Share:
Diluted Earnings per Share = Adjusted Net Income / Average Outstanding Shares
= ($91,784,000+$5,087,000)/(126,578+52,111+112)
= $96,871,000/178,801
Diluted Earnings per Share = $541.78
Archived Solution
You have full access to this solution. To save a copy with all formatting and attachments, use the button below.
For ready-to-submit work, please order a fresh solution below.
